BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 21242525)

  • 1. TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.
    Jelinek I; Leonard JN; Price GE; Brown KN; Meyer-Manlapat A; Goldsmith PK; Wang Y; Venzon D; Epstein SL; Segal DM
    J Immunol; 2011 Feb; 186(4):2422-9. PubMed ID: 21242525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TLR3-Mediated CD8+ Dendritic Cell Activation Is Coupled with Establishment of a Cell-Intrinsic Antiviral State.
    Széles L; Meissner F; Dunand-Sauthier I; Thelemann C; Hersch M; Singovski S; Haller S; Gobet F; Fuertes Marraco SA; Mann M; Garcin D; Acha-Orbea H; Reith W
    J Immunol; 2015 Aug; 195(3):1025-33. PubMed ID: 26101320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.
    Jirmo AC; Nagel CH; Bohnen C; Sodeik B; Behrens GM
    J Immunol; 2009 Jan; 182(1):283-92. PubMed ID: 19109159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
    Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
    J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new subset of CD103+CD8alpha+ dendritic cells in the small intestine expresses TLR3, TLR7, and TLR9 and induces Th1 response and CTL activity.
    Fujimoto K; Karuppuchamy T; Takemura N; Shimohigoshi M; Machida T; Haseda Y; Aoshi T; Ishii KJ; Akira S; Uematsu S
    J Immunol; 2011 Jun; 186(11):6287-95. PubMed ID: 21525388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the RIG-I pathway during influenza vaccination enhances the germinal center reaction, promotes T follicular helper cell induction, and provides a dose-sparing effect and protective immunity.
    Kulkarni RR; Rasheed MA; Bhaumik SK; Ranjan P; Cao W; Davis C; Marisetti K; Thomas S; Gangappa S; Sambhara S; Murali-Krishna K
    J Virol; 2014 Dec; 88(24):13990-4001. PubMed ID: 25253340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor 3 promotes cross-priming to virus-infected cells.
    Schulz O; Diebold SS; Chen M; Näslund TI; Nolte MA; Alexopoulou L; Azuma YT; Flavell RA; Liljeström P; Reis e Sousa C
    Nature; 2005 Feb; 433(7028):887-92. PubMed ID: 15711573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunoadjuvant effects of polyadenylic:polyuridylic acids through TLR3 and TLR7.
    Sugiyama T; Hoshino K; Saito M; Yano T; Sasaki I; Yamazaki C; Akira S; Kaisho T
    Int Immunol; 2008 Jan; 20(1):1-9. PubMed ID: 17981792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Single-Stranded Oligonucleotide Inhibits Toll-Like Receptor 3 Activation and Reduces Influenza A (H1N1) Infection.
    Poux C; Dondalska A; Bergenstråhle J; Pålsson S; Contreras V; Arasa C; Järver P; Albert J; Busse DC; LeGrand R; Lundeberg J; Tregoning JS; Spetz AL
    Front Immunol; 2019; 10():2161. PubMed ID: 31572376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice.
    Schneider-Ohrum K; Giles BM; Weirback HK; Williams BL; DeAlmeida DR; Ross TM
    Vaccine; 2011 Nov; 29(48):9081-92. PubMed ID: 21963872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide/protein immunization results in enhanced CTL responses with anti-tumor activity.
    Davila E; Celis E
    J Immunol; 2000 Jul; 165(1):539-47. PubMed ID: 10861094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A marked reduction in priming of cytotoxic CD8+ T cells mediated by stress-induced glucocorticoids involves multiple deficiencies in cross-presentation by dendritic cells.
    Hunzeker JT; Elftman MD; Mellinger JC; Princiotta MF; Bonneau RH; Truckenmiller ME; Norbury CC
    J Immunol; 2011 Jan; 186(1):183-94. PubMed ID: 21098225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses.
    Vabulas RM; Pircher H; Lipford GB; Häcker H; Wagner H
    J Immunol; 2000 Mar; 164(5):2372-8. PubMed ID: 10679072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of dendritic cells that cross-present tumor-derived antigen licenses CD8+ CTL to cause tumor eradication.
    van Mierlo GJ; Boonman ZF; Dumortier HM; den Boer AT; Fransen MF; Nouta J; van der Voort EI; Offringa R; Toes RE; Melief CJ
    J Immunol; 2004 Dec; 173(11):6753-9. PubMed ID: 15557168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyriboinosinic polyribocytidylic acid [poly(I:C)]/TLR3 signaling allows class I processing of exogenous protein and induction of HIV-specific CD8+ cytotoxic T lymphocytes.
    Fujimoto C; Nakagawa Y; Ohara K; Takahashi H
    Int Immunol; 2004 Jan; 16(1):55-63. PubMed ID: 14688061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccine molecules targeting Xcr1 on cross-presenting DCs induce protective CD8+ T-cell responses against influenza virus.
    Fossum E; Grødeland G; Terhorst D; Tveita AA; Vikse E; Mjaaland S; Henri S; Malissen B; Bogen B
    Eur J Immunol; 2015 Feb; 45(2):624-35. PubMed ID: 25410055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-Stranded Structure of the Polyinosinic-Polycytidylic Acid Molecule to Elicit TLR3 Signaling and Adjuvant Activity in Murine Intranasal A(H1N1)pdm09 Influenza Vaccination.
    Nakano T; Ohara Y; Fujita H; Ainai A; Yamamura ET; Suzuki T; Hasegawa H; Sone T; Asano K
    DNA Cell Biol; 2020 Sep; 39(9):1730-1740. PubMed ID: 32580635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor ligands modulate dendritic cells to augment cytomegalovirus- and HIV-1-specific T cell responses.
    Loré K; Betts MR; Brenchley JM; Kuruppu J; Khojasteh S; Perfetto S; Roederer M; Seder RA; Koup RA
    J Immunol; 2003 Oct; 171(8):4320-8. PubMed ID: 14530357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-stranded RNA exacerbates pulmonary allergic reaction through TLR3: implication of airway epithelium and dendritic cells.
    Torres D; Dieudonné A; Ryffel B; Vilain E; Si-Tahar M; Pichavant M; Lassalle P; Trottein F; Gosset P
    J Immunol; 2010 Jul; 185(1):451-9. PubMed ID: 20505141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TLR-independent induction of dendritic cell maturation and adaptive immunity by negative-strand RNA viruses.
    López CB; Moltedo B; Alexopoulou L; Bonifaz L; Flavell RA; Moran TM
    J Immunol; 2004 Dec; 173(11):6882-9. PubMed ID: 15557183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.